Pharmacokinetics and toxicology DRF studies - blackthorne LDT

Ended Awarded Last action

Contract number
75N95018F00003
Awardee
Awarding agency
Obligated
$439,962

Award facts

Opportunity
Contract value 71% obligated
  • $439,962.19 Current, with exercised options
  • $619,541.19 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 -$4,680
Funding Only Action P00005 -$15,223
Change Order P00004 $0
Supplemental Agreement for work within scope P00003 $220,124
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $239,742

About this award

This is a delivery order awarded to Southern Research Institute by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the U.S. Department of Health and Human Services. The $619,541.19 cost-plus-fixed-fee contract is for pharmacokinetics and toxicology studies in support of the Pharmacology and Toxicology for Therapeutics Program (PTTP), an indefinite-delivery, indefinite-quantity (ID/IQ) contract vehicle. This contract has no set-aside designation. Southern Research Institute, a non-profit organization, has previously performed research and development services for various federal agencies, including the National Institutes of Health, Department of Defense, and Environmental Protection Agency.

Quick answers

Who was awarded contract 75N95018F00003?

75N95018F00003 was awarded to Southern Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2018.

How much is contract 75N95018F00003 worth?

The government has obligated $439,962 on 75N95018F00003. Its potential value, with all options, is $619,541.

Which agency awarded contract 75N95018F00003?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00003, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Is contract 75N95018F00003 an order under another contract?

Yes. 75N95018F00003 is a delivery order under HHSN271201600007I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).

Was contract 75N95018F00003 competed?

The extent of competition for 75N95018F00003 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award